🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This real-word study is designed to prospectively explore whether local tre...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-10
Trial ID
NCT06690541
Treatments Being Tested
This trial is testing two novel combinations (temozolomide plus osimertinib...
Status
Completed
Location
University of Colorado Hospital
Start Date
2020-10-29
Trial ID
NCT04541407
Treatments Being Tested
A Phase 2, multi center, open label, dual cohort study to evaluate the effi...
Status
Completed
Location
Gaoxin Hospital of The First Affilated Hospital of Anhui Medical University
Start Date
2019-04-28
Trial ID
NCT03909971
Treatments Being Tested
The study will evaluate progression-free survival, overall survival, best r...
Status
Completed
Location
Aix-en-Provence - CH
Start Date
2019-02-01
Trial ID
NCT03727477
Lorlatinib is a third-generation, oral, reversible, ATP-competitive, macroc...
Status
Completed
Location
The Gujarat Cancer and Research Institute
Start Date
2020-08-27
Trial ID
NCT04541706
Treatments Being Tested
This observational study aims to evaluate the real-world effectiveness and ...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-01-31
Trial ID
NCT07374614
Treatments Being Tested
This is a multicenter, prospective, longitudinal observational study design...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-20
Trial ID
NCT06586801
Treatments Being Tested
The goal of this study is to determine the response of the study drug lorat...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2025-08-03
Trial ID
NCT06333899
The purpose of this study is to estimate the effect of rifampin on the sing...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2016-07
Trial ID
NCT02804399
Treatments Being Tested
This study will test the safety of the combination of ramucirumab and lorla...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Start Date
2023-08-17
Trial ID
NCT06007937
Treatments Being Tested